1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

ACTION ALERT: For residents of New York or Connecticut

July 31, 2018

IMPORTANT: This is a new action! Even if you’ve already contacted your congressional representatives about establishing the patient registry, please also take this action targeted at Congresswoman Nita Lowey (D-NY 17th District) and Congresswoman Rosa DeLauro (D-CT 3rd District).

In Other News

Mesothelioma and Mental Health

Mental health is a big issue for mesothelioma patients, caregivers, and family members. This session covers how patients as well as their loved ones can

CAR-T Cell Therapy as Treatment for Mesothelioma Patients

CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white

mesothelioma research

FDA Approves KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Patients with Unresectable or Metastatic Malignant Pleural Mesothelioma

For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with

Share:

Subscribe to our news

Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!

Patients and Families

About

Researchers

Read